(AP) -- The Food and Drug Administration has approved the first drug made specifically to treat cancer in dogs. Until now, all cancer drugs used in veterinary medicine were developed for use in humans and weren't specifically approved for animals. Federal law allows vets to administer cancer ...
“Diarrhea is a common side effect of chemotherapy in dogs, which can be so severe that cancer treatment must be halted. Chemotherapy drugs often have potential side effects, but, unlike in human medicine where patients may be willing to tolerate some discomfort in exchange for a potential cure...
Loyal’s research team is also advancing the development of two other drug formulations, LOY-002 and LOY-003, which would be available as daily oral medications. LOY-003 is specifically tailored for older dogs, excluding the smallest breeds. These drugs operate by inhibiting the action of a gr...
Dogs Join Fight against Bone Cancer; FDA-Approved Drugs to Be Tested on Canines with Bone Cancer That Also Affects HumansThompson, Dennis
The Federal Food, Drug, and Cosmetic Act gives FDA the legal authority to approve and regulate drugs for animals. Before a drug company can market an animal drug, the company must get the drug approved by FDA. However, in 2010 at least two veterinary drugs made by Teva Animal Health, Inc...
Designation of New Animal Drugs for Minor Uses or Minor Species (This guidance replaces the version dated September 1, 2010. This guidance updates contact information, adds a reference to the first question on page 8, and also reflects minor formatting changes.)Submit comments on this guidance ...
Animal Drugs View All Canine Librela Adverse Events Analyzed: CVM FDA says it has completed its evaluation of several adverse effects found in dogs treated with Librela for pain associated with osteoarthritis. Animal Drug Regs Amended to Reflect Approvals Federal Register notice: FDA amends ...
“Lymphoma is a devastating cancer in dogs, with few FDA-approved treatments available. This conditional approval provides a much-needed option to treat dogs with lymphoma,” said Steven M. Solomon, DVM, MPH, director of the FDA’s Center for Veterinary Medicine, in a prepared statement....
FDA Conditionally Approves First Drug for Nonregenerative Anemia in Cats With Chronic Kidney Disease Alana Hippensteele, Managing Editor May 2nd 2023 Article Clinical Trials of Veterinary Medications Differ From Drugs for Human Use Danielle K. Moorman;Joseph L. Fink III, JD, DSC (Hon), BSPharm...
Aducanumab (pronounced "add-yoo-CAN-yoo-mab") aims to help clear harmful clumps of a protein called beta-amyloid from the brain. Other experimental drugs have done that before but they made no difference in patients’ ability to think, care for themselves or live independently. ...